Hyperprolactinemia: pathophysiology and therapeutic approach
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Prolactin (PRL) is a hormone, mainly secreted by lactotroph cells of the anterior pituitary gland. Recent studies have shown it may also be produced by many extrapituitary cells. Its well-recognized PRL plays an important role in lactation during pregnancy, but it is involved in other biological functions such as angiogenesis, immunoregulation and osmoregulation. Hyperprolactinemia is a typical condition producing reproductive dysfunction in both sexes, resulting in hypogonadism, infertility and galactorrhea. It may be also asymptomatic. Lactotroph adenomas (prolactinoma) is one of the most common cause of PRL excess, representing approximately 40% of all pituitary tumors. Several other conditions should be excluded before a clear diagnosis of hyperprolactinemia is made. Hyperprolactinemia may be secondary to pharmacological or pathological interruption of hypothalamic-pituitary dopaminergic pathways or idiopathic. Stress, renal failure or hypothyroidism are other frequent conditions to exclude in patients with hyperprolactinemia. We will review biochemical characteristics and physiological functions of that hormone. Clinical and pharmacological approach to hyperprolactinemia will also be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prolactin: structure, function, and regulation of secretion
Freeman, M. E., Kanyicska, B., Lerant, A., & Nagy, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1523 · Cited by 2,457 · cited 1×
“However, PRL was found to produce ‘‘pleiotropic’’ effects, on metabolism, osmoregulation and immune and the nervous systems [2].”
BackgroundDiagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1692 · Cited by 1,844 · cited 10×
“Hyperprolactinemia may be due to medications, for example neuroleptics or antidepressants, or be idiopathic [1,6].”
BackgroundInfluentialLactation and maternal subclinical cardiovascular disease among premenopausal women
McClure, C. K., Catov, J. M., Ness, R. B., & Schwarz, E. B. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.04.030 · Cited by 68
Cited by
Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
Patel, S. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.04.008 · Cited by 605
Brown, R. S. E., Khant Aung, Z., Phillipps, H. R., Barad, Z., Lein, H.-J., Boehm, U., Szawka, R. E., & Grattan, D. R. (2019) · Endocrinology · doi:10.1210/en.2019-00038 · Cited by 62
Undurti, A., Colasurdo, E. A., Sikkema, C. L., Schultz, J. S., Peskind, E. R., Pagulayan, K. F., & Wilkinson, C. W. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00072 · Cited by 44
Abou-Kassem, D., Kurita, G. P., Sjøgren, P., & Diasso, P. D. K. (2022) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2021-0196 · Cited by 7
Metadata
- Authors
- Capozzi, A., Scambia, G., Pontecorvi, A., & Lello, S.
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2015-07-03
- Volume
- 31
- Issue
- 7
- Pages
- 506-510
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W1786600617
- Cited by
- 126
- References
- 3
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hyperprolactinemia: pathophysiology and therapeutic approach. https://app.cochat.ai/papers/10.3109/09513590.2015.1017810
- The paper
- Capozzi, A., Scambia, G., Pontecorvi, A., & Lello, S. (2015). Hyperprolactinemia: pathophysiology and therapeutic approach. Gynecological Endocrinology. https://doi.org/10.3109/09513590.2015.1017810
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.